Farlong Pharmaceutical Completes Three-Year Clinical Trial to Determine Effects of Farlong NotoGinseng™

Wednesday, February 5, 2020 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

Just in time for American Heart Health Month, Farlong releases study demonstrating extract's supplementation has a positive influence on reducing the risk of cardiovascular disease

WALNUT, Calif., Feb. 5, 2020 /PRNewswire-PRWeb/ -- Just in time for American Heart Health Month, Farlong Pharmaceutical, a vertically integrated, plant-based ingredient and supplement company, announces the clinical trial results from a randomized, placebo-controlled, double-blind, parallel study on one hundred healthy adults to determine the effect of Farlong NotoGinseng™ (Farlong Ginseng Plus® Panax Notoginseng extract) on cholesterol and blood pressure, conducted December 2016 through June 2019.

The findings of this study demonstrate that Farlong NotoGinseng™ (Farlong Ginseng Plus® Panax Notoginseng extract) supplementation is well tolerated and has a positive influence on reducing the risk of cardiovascular disease by decreasing blood pressure and selectively increasing HDL-C.

Sponsored by Farlong Pharmaceutical and conducted by KGK Science, Inc., the primary objective was the difference in serum LDL-C from baseline to week 12 between Farlong NotoGinseng™ and placebo after 12 weeks of supplementation. The secondary objectives were the difference in serum LDL-C, blood pressure, triglycerides, HDL-C, total cholesterol and in endothelial vasodilation as measured by the EndoPAT from baseline to week eight and week 12 between Farlong NotoGinseng™ and placebo.

Over a 12-week period, the participants were given one serving (two capsules) of the investigational product or placebo to take orally at the same time every day, 30 minutes before a meal for 84 days.

The results showed a significant decrease in serum LDL-C in Farlong NotoGinseng™ group from baseline to week eight. LDL Cholesterol is sometimes called the "bad" cholesterol because a high LDL level leads to a buildup of cholesterol in people's arteries. There was a slight increase in serum HDL-C following 12 weeks of supplementation with Farlong NotoGinseng™. HDL (high-density lipoproteins) cholesterol is the "good" cholesterol. There were also within-group decreases in both systolic and diastolic blood pressures.

The placebo group had increases in systolic and diastolic blood pressures and a decrease in serum HDL-C. Clinicians suggest that if left unaddressed, these participants may progress to a disease state, and even a small reduction in blood pressure is clinically meaningful in populations at risk for developing cardiovascular diseases.

To review the full clinical study and results, please contact info@farlong.com or (888) 327-5664.

Farlong NotoGinseng™ is designed to help maintain normal health of the cardiovascular system. The capsule consists of highly concentrated pharmaceutical grade Ginseng Plus® Panax Notoginseng extract, containing high potency notoginsenoside R1, ginsenoside Rb1, ginsenoside Rg1, which are the most active components along with other minor ginsenosides, such as ginsenoside Rd, Re, Rb2 and Rg3, ext. to nutritionally support healthy heart function, blood circulation, and performance.

For more than 20 years, Farlong has created products using natural and herbal ingredients to promote a healthy and natural life, focusing on top quality ingredients and ancient Chinese roots. Farlong produces Panax Notoginseng from seed to shelf, beginning at their 6,000-acre GAP farm located in Yunnan Province, where 75% of world's medicinal botanicals originate from. The geographical area of the farm's location is known for harvesting specific medicinal Chinese herbs, proven to benefit the health and improvement for a variety of health conditions. Farlong combines traditional processing methods with the most advanced techniques, ensuring that all decoction ingredients are transferred to full-spectrum concentrated ingredients while achieving greater levels of stability and effectiveness.

About Farlong Pharmaceutical: Since 1998, Farlong Pharmaceutical has combined ancient Oriental medicine and modern technology to create a line of natural and safe products that promote a healthy life. Farlong is a vertically integrated herbal ingredient and supplement company with its own GAP (Good Agricultural Practice) certified cultivation base, cGMP (Current Good Manufacturing Practice), certified manufacturing facilities and distribution channels for its unique and effective ingredients and formulas, including InnerPure® for colon detoxing, Lifeflower® breviscapine for cognitive health, Ginseng Plus® Panax Notoginseng™ extract for heart health and AstaBest™ Astaxanthin for antioxidant nutrition. For more information, visit Farlong.com for supplements and 300+ ingredients, and follow on Facebook, Twitter and Instagram.

 

SOURCE Farlong Pharmaceutical



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Premium Membership Benefits

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store